Related Experiment Videos
Race and gender differences in C-reactive protein levels
Amit Khera1, Darren K McGuire, Sabina A Murphy
1Donald W. Reynolds Cardiovascular Clinical Research Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9047, USA. amit.khera@utsouthwestern.edu
Journal of the American College of Cardiology
|August 2, 2005
Summary
C-reactive protein (CRP) levels show significant race and gender disparities. Black individuals and women have higher CRP, impacting cardiovascular risk assessment, necessitating further research for tailored thresholds.
Area of Science:
- Biomarkers and Cardiovascular Health
- Population Health and Epidemiology
- Clinical Chemistry
Background:
- Limited data exist on C-reactive protein (CRP) distributions across diverse racial and gender groups.
- Current clinical guidelines propose a uniform CRP threshold (>3 mg/l) for cardiovascular risk assessment.
- Understanding these distributions is crucial for accurate risk stratification.
Purpose of the Study:
- To investigate potential race and gender differences in C-reactive protein (CRP) levels.
- To compare CRP distributions among different race and gender strata within a population sample.
- To inform the clinical utility of CRP in cardiovascular risk assessment across diverse demographics.
Main Methods:
- Analysis of CRP levels in 2,749 Black and White subjects (ages 30-65) from the Dallas Heart Study.
- Comparison of CRP distributions between different race and gender groups.
- Statistical adjustment for cardiovascular risk factors, hormone use, and body mass index.
Main Results:
- Black subjects exhibited higher median CRP levels (3.0 mg/l) than White subjects (2.3 mg/l).
- Women displayed higher median CRP levels (3.3 mg/l) compared to men (1.8 mg/l).
- Elevated CRP (>3 mg/l) was significantly more prevalent in Black women and White women than in White men, even after adjustments.
Conclusions:
- Substantial race and gender variations exist in population CRP levels.
- The clinical significance of these race and gender differences in CRP requires further investigation regarding cardiovascular outcomes.
- Consideration of race- and gender-specific thresholds for CRP in cardiovascular risk assessment may be warranted.